Nick von Westenholz, CPA CEO said;
“Glyphosate is a cornerstone of sustainable, productive agriculture and a product which scientists and regulators are more than satisfied can be used safely. It is hugely disappointing that the European Parliament has failed to reach a qualified majority on its re-licensing.
“Over 40 years of robust scientific evidence has confirmed that glyphosate poses no unacceptable risk to human health and that there is no cancer or endocrine disruptor risk. In fact, no regulatory agency in the world classifies glyphosate as a carcinogen. This is in stark contrast to the surprising IARC classification of glyphosate as a “probable carcinogen”. The World Health Organisation itself recently clarified its position at the UN’s Joint Meeting on Pesticide Residues, stating that glyphosate was “unlikely to pose a carcinogenic risk to humans”.
“It is unfortunate that the debate around glyphosate has become politicised, causing some to lose sight of the overwhelming scientific evidence. Failure to relicense glyphosate would be contrary to the science, provide no benefit to human health, wildlife or the environment and at the same time undermine our ability to produce a safe, affordable supply of food.
“We now urge the European Commission to take the sensible, science led decision to re-licence this incredibly safe, efficient and effective product, and ensure farmers have access to the tools they need to grow a healthy, safe, reliable and affordable supply of food.”